Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Duffy

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2008
ADAM-17 predicts adverse outcome in patients with breast cancerP M McGowan, E McKiernan, F Bolster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2011
Src: a potential target for the treatment of triple-negative breast cancerD Tryfonopoulos, S Walsh, D M Collins, et al.
Journal of Medicinal Chemistry|August 6, 1993
Anticonvulsant activities of some arylsemicarbazones displaying potent oral activity in the maximal electroshock screen in rats accompanied by high protection indicesJ R Dimmock, K K Sidhu, R S Thayer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2012
ADAM-17: a novel therapeutic target for triple negative breast cancerP M McGowan, M Mullooly, F Caiazza, et al.
Journal of Pharmaceutical Sciences|December 1, 1992
Evaluation of cytotoxicity of some Mannich bases of various aryl and arylidene ketones and their corresponding arylhydrazonesJ R Dimmock, K M Advikolanu, H E Scott, et al.
Oncology Reports|June 10, 2005
Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaborationN Grebenchtchikov, T M Maguire, R Riisbro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1B M Ryan, G E Konecny, S Kahlert, et al.
British Journal of Cancer|March 20, 2003
Elevated expression and altered processing of fibulin-1 protein in human breast cancerL M Greene, W O Twal, M J Duffy, et al.
British Journal of Cancer|November 13, 2008
Protein kinase Cdelta expression in breast cancer as measured by real-time PCR, western blotting and ELISAE McKiernan, K O'Brien, N Grebenchtchikov, et al.
The Review of Scientific Instruments|May 3, 2011
A comb-sampling method for enhanced mass analysis in linear electrostatic ion trapsJ B Greenwood, O Kelly, C R Calvert, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2008
ADAM-17 predicts adverse outcome in patients with breast cancerP M McGowan, E McKiernan, F Bolster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2011
Src: a potential target for the treatment of triple-negative breast cancerD Tryfonopoulos, S Walsh, D M Collins, et al.
Journal of Medicinal Chemistry|August 6, 1993
Anticonvulsant activities of some arylsemicarbazones displaying potent oral activity in the maximal electroshock screen in rats accompanied by high protection indicesJ R Dimmock, K K Sidhu, R S Thayer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2012
ADAM-17: a novel therapeutic target for triple negative breast cancerP M McGowan, M Mullooly, F Caiazza, et al.
Journal of Pharmaceutical Sciences|December 1, 1992
Evaluation of cytotoxicity of some Mannich bases of various aryl and arylidene ketones and their corresponding arylhydrazonesJ R Dimmock, K M Advikolanu, H E Scott, et al.
Oncology Reports|June 10, 2005
Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaborationN Grebenchtchikov, T M Maguire, R Riisbro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1B M Ryan, G E Konecny, S Kahlert, et al.
British Journal of Cancer|March 20, 2003
Elevated expression and altered processing of fibulin-1 protein in human breast cancerL M Greene, W O Twal, M J Duffy, et al.
British Journal of Cancer|November 13, 2008
Protein kinase Cdelta expression in breast cancer as measured by real-time PCR, western blotting and ELISAE McKiernan, K O'Brien, N Grebenchtchikov, et al.
The Review of Scientific Instruments|May 3, 2011
A comb-sampling method for enhanced mass analysis in linear electrostatic ion trapsJ B Greenwood, O Kelly, C R Calvert, et al.
Pageof 12